AI-generated summary
The authors report a randomized triple-blind trial in 22 patients with myofascial pain dysfunction syndrome, comparing photobiomodulation at 630 and 810 nm with sham laser, both alongside standard conservative care. Both groups showed significant pain reduction and jaw opening improvement over time, with no significant difference between groups in the rate of improvement. The authors state the findings were comparable to conventional care alone.
- Participants
- 22
- Who or what was studied
- Patients with myofascial pain dysfunction syndrome
- Wavelengths
- 630, 810 nm
- Limits stated in the abstract
- The trial included only 22 patients, with 11 per group, and the abstract does not state a limitation beyond this small sample.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Power
- 200 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Randomized controlled trial, Visual analogue scale, Control group, Fluence, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.